SIGA - NASDAQ

SIGA Technologies, Inc.

SIGA Technologies, Inc.

SIGA·NASDAQ

$4.29

-0.69%
HealthcareDrug Manufacturers - Specialty & Generic

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$307.70M
EPS0.3300
P/E Ratio13.00
Earnings Date07/30/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

SIGA Technologies, Inc.

SIGA Technologies, Inc. Earnings Call Transcripts

SIGA · NASDAQ

Related Guides

Blog Categories

Continue your SIGA research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.